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Abstract  
Leiomyosarcoma is a rare tumor of the smooth muscle, but relatively frequent in the stomach and the small intestine. The mesocolic site is rare. 
Globally, leimyosarcoma represents less than 0, 1% of the malignant tumors found in the colon and the anus. Because of the similarities with other 
digestive tumors, namely mesenchymatous or benign tumors of the smooth muscle, the diagnosis of a pleomorphic sarcoma remains difficult even 
at the histological stage. Surgery is the mainstay of the therapy. We report a case of leiomyosarcoma of the mesocolon and discuss about its main 
characteristics in the view of the current literature about this pathological condition. 
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Introduction 
 
Soft tissue sarcomas (STS) are an extremely diverse group of 
tumors occurring in every region of the human body and affecting 
all ages with significant morbidity and mortality. Soft tissue 
sarcomas include more than 35 different neoplasms derived from 
fat, muscle, nerve, fibrous, vascular, or deep skin tissue, and can be 
classified by their tissue of origin or their anatomical location [1]. 
The World Health Organization classifies liposarcomas into 5 
histologic subtypes: welldifferentiated, dedifferentiated, myxoid, 
round cell, and pleomorphic sarcomas. Dedifferentiated histologic 
subtypes have a worse prognosis and an increased risk of local 
recurrence compared with well- differentiated liposarcomas [2]. 
Therefore, aggressive complete surgical resection of the tumor and 
adjacent organs is the mainstay of treatment for dedifferentiated 
liposarcomas [2]. We report here a case of pleomorphic 
leiomyosarcoma arising from the mesocolon and discuss its main 
characteristics and the management of this tumor along with a 
review of the literature. 
  
  
Patient and observation 
 
A - 62-year- old female patient, who had past medical history of 
well treated pulmonary tuberculosis 6 years ago, that hospitalized 
because of a chronic abdominal pain for 10months.The patient 
reported weight loss about 6-kg during her illness .The physical 
examination found palpable per-umbilical mass (10 cm of diameter), 
hard and mobile relatively to the deeper and superficial neighboring 
structures. No lymph node or ascites was found. Laboratory exams: 
complete blood count was in normal range and tumor markers were 
negative. 
  
Computer tomography scanning of the abdomen showed a round 
tissular mass with irregular edges, which makes 14 cm in its great 
axis, with central necrotic areas enhancement in the peripheral 
zones (Figure 1). A primitive pelvic tumor was suspected. At 
laparotomy exploration, the surgeons noted a pink multiloblar tumor 
of the transverse mesocolon of 15 cm is his greatest axis, without 
any ascites or peritoneal carcinoid. The surgeons performed a 
resection of the tumor and the adjacent part of the mesocolon 
(Figure 2). 
  
On macroscopically exam, the tumor was 15cm of diameter, firm 
with necrotic areas. Histopathological examination combined with 
immunohistochemical studies established the diagnosis of 
pleomorphous sarcoma of the mesocolon. The postoperative course 





Pleomorphous sarcomas represent approximately 10 to 15% of the 
sarcoma of the smooth tissues of the adult [3]. The mean age at 
occurrence is about the 6th decade of the life [4]. There is a slight 
male predominance, with a sex ratio of 1,6 [5,6]. 
  
The clinical symptomatology is not specific; can be abdominal pain 
or mass [7-9], alteration in the general condition [10, 11], or signs 
related to a vascular or nervous compression [10] can all be 
experienced by the patient. Hepatic and pulmonary metastasis can 
be observed in the course of a leiomyosarcoma of the mesocolon. 
They represented the main causes of the death. Involvement of the 
nodes is rare [10]; ultrasonography and computer tomographic 
scanning of the abdomen are very helpful in view of the diagnosis of 
leiomyosarcoma. Leiomyosarcoma usually appears at 
ultrasonography as a high volume and irregular mass with multiples 
echogenic lobes, and central cavity of necrotic areas .Computer 
tomography scanning also exhibits a rounded in homogenous 
tissular mass with irregular edges, central necrotic areas and 
enhancement of the peripheral zone. 
  
Pathological exam combined with immunohistochemical studies 
usually confirms the diagnosis of pleomorphous sarcomas are 
defined as mesenchymal tumors consisting on pleomorphic spindle- 
cells with different forms and size and the pleomorphic is high 
lightened by the nuclear atypical and the anyso caryopses [3]. 
  
Durant the years 1980 [3], a balanced proposition of pleomorphous 
sarcoma was classified as malignant histocytofibromas (MHF). 
Currently, the MHF is no way considered as a specific clinic 
pathologic entity but just as a morphological feature seen in many 
tumors, including melanomas, lymphomas and carcinomas. Because 
of the progress in immunohistochemistry and electronic microscopy, 
some criteria's have been included in order to make a 
subclassification of the pleomorphous sarcoma entity. 
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Macroscopically, pleomorphous sarcoma presents as a white to 
grey-pinked hard and firm great mass, sometimes elastic or 
renittent. More it is more than 10 cm, the tumor is generally 
lobulated with smooth areas corresponding to intratumoral necrotic 
zones, and recovered by a complex channel of blood vessels. 
  
At the microscopic level, pleomorphous leiomyosarcoma contain 
pleomorphous cells, which are around and spindle shaped, 
extending as longs fasciles takings contact the ones to others in 
rights angles. Atypical cells are frequents because of the presence 
of giants cells, normal and abnormal mitosis. The cells have an 
abundant eosinophil and fibrillary cytoplasm.The nucleus muscle 
and desmine (50 to 70% of all the cases) [3]. 
  
The differential diagnosis is essentially with others clinical entities 
such as undifferenciated pleomorphous sarcoma, gastro-intestinal 
tumors of the stroma, pleomorphous rhabdomyosarcoma. 
Immunohistochemistry studies allow performing the diagnosis [3]. 
  
The benign or malignant nature of a pleomorphous sarcoma is not 
always easy to establish. Grading's system relying on histological 
parameters that have been described in order to better differentiate 
between the different tumoral grades and so the prognosis [12]. 
Like for the other sarcoma of the smooth tissues, prognostic factors 
on the histological type, the depth of the tumor, the high grade , 
the tumor size ( more than 5cm ) , tumoral necrosis great mitotic 
activity, infiltration in the neighboring structures, vascular invasion 
and the localization other than a limb, recurrence. Generally 
pleomorphous leiomorphous are considered as very aggressive and 
metastatic pleomorphous sarcomas. 
  
Moreover, it has been shown that myogenic differentiation was a 
deleterious prognostic factors [13]. The treatment of pleomorphous 
sarcomas rely on surgery. The excision of the tumor in a monobloc 
fashion, with the viscera and without any tumoral effraction, is the 
standard of therapy [7]. Nodes excision is not systematic because 
involvement or recurrences at these sites are rare [8]. The high 
recurrence rate after surgery has led to investigations into the use 
of combined modality treatment for these tumours. As the most 
common form of relapse in retroperitoneal sarcoma is a local 
recurrence, adjuvant radiotherapy has been proposed to enhance 
the cure rates and improve the relapse free survival. Studies in 
extremity sarcomas have demonstrated improved local control rates 
when surgery was combined with radiotherapy. Globally, the 
sensitivity of sarcomas to irradiation is low [14]. However, there is 
no consensus regarding use of neoadjuvant or adjuvant 
chemotherapy. Neo adjuvant chemotherapy (NACT) is given with an 
aim to improve the resectability of the tumour. The advantages of 
NACT are a reduction in the size of tumours, probability of a margin 
negative resection and determining the tumour response to 
chemotherapy. In addition, any micrometastatic disease could be 
controlled. The disadvantages are that a tumour may not respond to 
chemotherapy and a potentially resectable tumour may become 
inoperable. Chemotherapy may also worsen the performance status 
of the patient [14]. Several studies, most of them non-randomized 
have not shown any consistent benefit withNACT. In one large 
study, Meric et al,reported results of 65 patients of RPS with NACT 
doxorubicin or ifosfamide, of these 23 had resectable RPS [15]. 
  
After surgical treatment, the course of pleomorphous sarcoma is 
characterized by the high frequency of local recurrences, as up as 
44% to 85% [7, 11]. The management of these recurrences relies 
on iterative surgeries. The global rate of survival at 5 years is about 





Pleomorphous leiomysarcoma of the mesocolon is a rare tumor. The 
positive diagnosis of this condition can be made on pathological 
exam combined with immunohistochemistry studies after surgery. 
The association of an adjuvant therapy remains controversial; 
however, adjuvant chemotherapy can be suggested in the case of a 










All authors are fully participated in the study design, performed the 
analysis, and wrote the manuscript. All authors read and approved 
the final manuscript. 
  
  
Page number not for citation purposes 4 
Figures 
 
Figure 1: CT scan of the abdomen showing a round tissular mass 
with irregular edges with central necrotic areas enhancement in the 
peripheral zones 
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Figure 1: CT scan of the abdomen showing a round tissular mass with 







Figure 2: Removed specimen of the tumor and the adjacent part of 
the mesecolon 
 
